Design and development of magnetoliposome-based theranostics

Materials and Manufacturing Processes

Volumn 23, Issue 6, 2008, Pages 611-614

  Soenen, S J H ^a   Cocquyt, J ^b   Defour, L ^a   Saveyn, P ^b   Van Der Meeren, P ^b   De Cuyper, M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Cell labelling; Drug delivery; Drug sorption; High gradient magnetophoresis; Magnetoliposomes; Phospholipid bilayer

Indexed keywords

CELL CULTURE; CHEMOTHERAPY; DRUG DELIVERY; DRUG DOSAGE; HEALTH; IMAGING TECHNIQUES; IRON ORES; MAGNETIC FIELDS; MAGNETIC RESONANCE IMAGING; MAGNETITE; OXIDE MINERALS; PHOSPHOLIPIDS; RESONANCE;

AMPHIPHILIC(AP); BI LAYERS; CELL MODELING; CELL-VIABILITY; CONTRAST AGENT (CA); DELIVERY SYSTEMS; DESIGN AND DEVELOPMENT; DIAGNOSTIC IMAGING; DIMYRISTOYL PHOSPHATIDYLCHOLINE (DMPC); MAGNETIC RESONANCE IMAGING (MRI); MAGNETITE CORES; MAGNETOLIPOSOMES (ML); NANO SCALING; NANO-COLLOIDS; NANOMETRE; PHOSPHOLIPID MOLECULES; PROOF-OF-CONCEPT (POC);

NANOSTRUCTURED MATERIALS;

EID: 47049094177     PISSN: 10426914     EISSN: 15322475     Source Type: Journal    
DOI: 10.1080/10426910802160635     Document Type: Conference Paper

References (23)

1. De Cuyper, M.; Joniau, M. Magnetoliposomes: Formation and structural characterisation. European Biophysical Journal 1988, 15, 311-319.
2. Da Silva, M.F.; Garcia, V.A.P.; Lacava, L.M.; Kückelhaus, S.; Azevedo, R.B.; Morais, P.C.; De Cuyper, M.; Lacava, Z.G.M. Magnetoliposome evaluation using cytometry and micronucleus test. European Cells Materials 2002, 3 Suppl. 2, 154-155.
3. Soenen, S.J.H.; Baert, J.; De Cuyper, M. Optimal conditions for labelling of 3T3 fibroblasts with magnetoliposomes without affecting cellular viabilities. ChemBioChem 2007, 8, 2067-2077.
4. De Cuyper, M. Applications of magnetoproteoliposomes in bioreactors operating in high-gradient magnetic fields. In Handbook of Non-Medical Applications of Liposomes. Vol. 3, From design to microreactors. CRC Press: Boca Raton, FL, 1996; 323-340.
5. Bulte, J.W.M.; De Cuyper, M. Magnetoliposomes as contrast agents. Methods in Enzymology 2003, 373, 175-198.
6. Zhang, J.Q.; Zhang, Z.R.; Yang, H.; Tan, Q.Y.; Qin, S.R.; Qiu, X.L. Lyophilized Paclitaxel magnetoliposomes as a potential drug delivery system for breast carcinoma via parenteral administration: In vitro and in vivo studies. Pharmaceutical Research 2005, 22, 573-583.
7. Cocquyt, J. Structure and Sorption Behaviour of Liposomal Dispersions. PhD thesis, Faculteit Bio-Ingenieurswetenschappen, University Gent, 165 pp., 2005.
8. Bucak, S.; Jones, D.A.; Laibinis, P.E.; Hatton, T.A. Protein separations using colloidal magnetic nanoparticles. Biotechnology Progress 2003, 19, 477-484.
9. Khalafalla, S.E.; Reimers, G.W. Preparation of dilution-stable aqueous magnetic fluids. IEEE Transactions on Magnetics 1980, 16, 178-183.
10. De Cuyper, M.; Caluwier, D.; Baert, J.; Cocquyt, J.; Van der Meeren, P. A successful strategy for the production of cationic magnetoliposomes. Zeitschrift für Physikalische Chemie 2006, 220, 133-141.
11. Cocquyt, J.; Saveyn, P.; Van der Meeren, P.; De Cuyper, M. Evaluation of the interaction of propranolol with DMPC liposomes: The partitioning model. Langmuir 2007, 23, 1959-1964.
12. Bulte, J.W.M.; Arbab, A.S.; Douglas, T.; Frank, J.A. Preparation of magnetically labeled cells for cell tracking by Magnetic Resonance imaging. Methods in Enzymology 2004, 386, 275-299.
13. 3H]propranolol between MDCK cell lipid vesicles and buffer. Pharmaceutical Research 1996, 13, 1851-1855.
14. Surewicz, W.K.; Leyko, W. Interaction of propranolol with model phospholipid membranes - Monolayer, spin label and fluorescence spectroscopy studies. Biochimica Biophysica Acta 1981, 643, 387-397.
15. Makino, K.; Yamada, T.; Kimura, M.; Oka, T.; Ohshima, H.; Kondo, T. Temperature- and ionic strength-induced conformational changes in the lipid head group region of liposomes as suggested by zeta potential data. Biophysical Chemistry 1991, 41, 175-183.
16. Sun, Z.-X.; Su, F.-W.; Forsling, W.; Samskog, P.-O. Surface characteristics of magnetite in aqueous suspension. Journal of Colloid and Interface Science 1998, 197, 151-159.
17. Avdeef, A.; Box, K.J.; Comer, J.E.A.; Hibbert, C.; Tam, K.Y. pH-Metric logP 10. Determination of liposomal membrane-water partition coefficients of ionizable drugs. Pharmaceutical Research 1998, 15, 209-215.
18. Van den Bos, E.J.; Wagner, A.; Mahrholdt, H.; Thompson, R.B.; Morimoto, Y.; Sutton, B.S.; Judd, R.M.; Taylor, D.A. Improved efficacy of stem cell labeling for Magnetic Resonance imaging studies by use of cationic liposomes. Cell Transplantion 2003, 12, 743-756.
19. Becker, C.; Hodenius, M.; Blendinger, G.; Sechi, A.; Hieronymus, T.; Müller-Schulte, D.; Schmitz-Rode T.; Zenke, M. Uptake of magnetic nanoparticles into cells for cell tracking. Journal of Magnetism and Magnetic Materials 2007, 311, 234-237.
20. Lemke, A.-J.; Senfft von Pilsach, M.-I.; Lübbe, A.; Bergemann, C.; Riess, H.; Felix, R. MRI after magnetic drug targeting in patients with advanced solid malignant tumors. European Radiology 2004, 14, 1949-1955.
21. Neuberger, T.; Schöpf, B.; Hofmann, H.; Hofman, M.; von Rechenberg, B. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. Journal of Magnetism and Magnetic Materials 2005, 293, 483-496.
22. Dobson, J.; Magnetic nanoparticles for drug delivery. Drug Development Research 2006, 67, 55-60.
23. Arruebo, M.; Fernández-Pacheco, R.; Ricardo Ibarra M.; Santamaria, J.; Magnetic particles for drug delivery. NanoToday 2007, 2, 22-32.